1168 related articles for article (PubMed ID: 11147289)
1. Spina bifida and other neural tube defects.
Northrup H; Volcik KA
Curr Probl Pediatr; 2000; 30(10):313-32. PubMed ID: 11147289
[TBL] [Abstract][Full Text] [Related]
2. Does prenatal screening for 5,10-methylenetetrahydrofolate reductase (MTHFR) mutations in high-risk neural tube defect pregnancies make sense?
Finnell RH; Shaw GM; Lammer EJ; Volcik KA
Genet Test; 2002; 6(1):47-52. PubMed ID: 12180076
[TBL] [Abstract][Full Text] [Related]
3. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.
Shaw GM; Lammer EJ; Zhu H; Baker MW; Neri E; Finnell RH
Am J Med Genet; 2002 Feb; 108(1):1-6. PubMed ID: 11857541
[TBL] [Abstract][Full Text] [Related]
4. Spina bifida.
Copp AJ; Adzick NS; Chitty LS; Fletcher JM; Holmbeck GN; Shaw GM
Nat Rev Dis Primers; 2015 Apr; 1():15007. PubMed ID: 27189655
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
Lary JM; Edmonds LD
MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
[TBL] [Abstract][Full Text] [Related]
6. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression.
Beaudin AE; Stover PJ
Birth Defects Res C Embryo Today; 2007 Sep; 81(3):183-203. PubMed ID: 17963270
[TBL] [Abstract][Full Text] [Related]
7. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
Harris MJ; Juriloff DM
Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
[TBL] [Abstract][Full Text] [Related]
8. Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study.
Martínez de Villarreal LE; Delgado-Enciso I; Valdéz-Leal R; Ortíz-López R; Rojas-Martínez A; Limón-Benavides C; Sánchez-Peña MA; Ancer-Rodríguez J; Barrera-Saldaña HA; Villarreal-Pérez JZ
Arch Med Res; 2001; 32(4):277-82. PubMed ID: 11440783
[TBL] [Abstract][Full Text] [Related]
9. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida.
Shaw GM; Rozen R; Finnell RH; Wasserman CR; Lammer EJ
Am J Epidemiol; 1998 Jul; 148(1):30-7. PubMed ID: 9663401
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.
Volcik KA; Shaw GM; Lammer EJ; Zhu H; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):154-7. PubMed ID: 12797455
[TBL] [Abstract][Full Text] [Related]
11. Etiology, pathogenesis and prevention of neural tube defects.
Padmanabhan R
Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
[TBL] [Abstract][Full Text] [Related]
12. Folate status and neural tube defects.
Molloy AM; Mills JL; Kirke PN; Weir DG; Scott JM
Biofactors; 1999; 10(2-3):291-4. PubMed ID: 10609896
[TBL] [Abstract][Full Text] [Related]
13. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c --> t methylenetetrahydrofolate reductase and 2756a --> g methionine synthase genotypes.
Lucock M; Daskalakis I; Briggs D; Yates Z; Levene M
Mol Genet Metab; 2000 May; 70(1):27-44. PubMed ID: 10833329
[TBL] [Abstract][Full Text] [Related]
14. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population.
Barber R; Shalat S; Hendricks K; Joggerst B; Larsen R; Suarez L; Finnell R
Mol Genet Metab; 2000 May; 70(1):45-52. PubMed ID: 10833330
[TBL] [Abstract][Full Text] [Related]
15. Inositol, neural tube closure and the prevention of neural tube defects.
Greene ND; Leung KY; Copp AJ
Birth Defects Res; 2017 Jan; 109(2):68-80. PubMed ID: 27324558
[TBL] [Abstract][Full Text] [Related]
16. Neural tube defects: Prevalence, mortality, and maternal characteristics in two departmental hospitals in the northwestern region of Nicaragua, 2006-2018.
Pastora Bucardo DM; González F; Montes Pastora M; Pimienta Ramirez PA; Bonilla IL; Vielot NA; Finnell RH
Birth Defects Res; 2023 May; 115(9):945-953. PubMed ID: 37025002
[TBL] [Abstract][Full Text] [Related]
17. Neural tube defects: recent advances, unsolved questions, and controversies.
Copp AJ; Stanier P; Greene ND
Lancet Neurol; 2013 Aug; 12(8):799-810. PubMed ID: 23790957
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.
De Marco P; Calevo MG; Moroni A; Arata L; Merello E; Cama A; Finnell RH; Andreussi L; Capra V
Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S14-7. PubMed ID: 11813127
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of neural tube defects.
Frey L; Hauser WA
Epilepsia; 2003; 44 Suppl 3():4-13. PubMed ID: 12790881
[TBL] [Abstract][Full Text] [Related]
20. [THE DIFFERENTIATED APPROACH TO PREVENTION OF NEURAL TUBE DEFECTS IN CHILDREN].
Kotova N; Maichuk V; Fedorenko O
Georgian Med News; 2018 Jan; (274):52-59. PubMed ID: 29461227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
